Compugen (CGEN) Current Leases (2019 - 2026)

Compugen recorded quarterly Current Leases of $559000.0 in Q1 2026, up 7.29% quarter-over-quarter from $521000.0 in Q4 2025.

Compugen's Current Leases history runs 7 years deep, the most recent figure standing at $559000.0 for Q1 2026.

  • In Q1 2026, Current Leases changed N/A year-over-year to $559000.0; the TTM figure through Mar 2026 stood at $559000.0 (changed N/A YoY), while the FY2025 annual figure was $521000.0, up 16.29% from the prior year.
  • Current Leases came in at $559000.0 for Q1 2026 at Compugen, up from $521000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $632000.0 in Q4 2023 to a low of $448000.0 in Q4 2024.
  • A 5-year average of $554600.0 and a median of $559000.0 in 2026 frame the typical range for Current Leases.
  • Across the five-year window, Current Leases slipped 29.11% in 2024 and increased 16.29% in 2025, its largest moves.
  • Compugen's Current Leases stood at $613000.0 in 2022, then climbed by 3.1% to $632000.0 in 2023, then retreated by 29.11% to $448000.0 in 2024, then climbed by 16.29% to $521000.0 in 2025, then climbed by 7.29% to $559000.0 in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $559000.0, $521000.0, and $448000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 559,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 559,000.00
Dec 31, 2025 521,000.00
Sep 30, 2025 486,000.00
Jun 30, 2025 471,000.00
Mar 31, 2025 423,000.00
Dec 31, 2024 448,000.00
Sep 30, 2024 447,000.00
Jun 30, 2024 449,000.00
Mar 31, 2024 441,000.00
Dec 31, 2023 632,000.00
Sep 30, 2023 592,000.00
Jun 30, 2023 610,000.00
Mar 31, 2023 617,000.00
Dec 31, 2022 613,000.00
Sep 30, 2022 595,000.00
Jun 30, 2022 615,000.00
Mar 31, 2022 764,000.00
Dec 31, 2021 768,000.00
Sep 30, 2021 760,000.00
Jun 30, 2021 706,000.00
Mar 31, 2021 694,000.00
Dec 31, 2020 639,000.00
Sep 30, 2020 523,000.00
Jun 30, 2020 519,000.00
Mar 31, 2020 489,000.00
Dec 31, 2019 600,000.00
Sep 30, 2019 629,000.00
Jun 30, 2019 1.18 Mn